The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia
Introduction:The efficacy and safety of immunosuppressive therapy in Coronavirus disease-2019 (COVID-19) still controversial. We evaluated the effects of immunosuppressive therapy on mortality in patients followed in the intensive care units (ICU) due to critical COVID-19 pneumonia.Methods:We compar...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2022-05-01
|
| Series: | İstanbul Medical Journal |
| Subjects: | |
| Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-effects-of-mmunosuppressive-therapy-on-mortali/52047
|
| _version_ | 1797915918966194176 |
|---|---|
| author | Ömer Ayten İnşa Gül Ekiz İşcanlı Ekiz İşcanlı Gözde Kalbaran Kısmet Cengiz Özdemir Bengü Şaylan |
| author_facet | Ömer Ayten İnşa Gül Ekiz İşcanlı Ekiz İşcanlı Gözde Kalbaran Kısmet Cengiz Özdemir Bengü Şaylan |
| author_sort | Ömer Ayten |
| collection | DOAJ |
| description | Introduction:The efficacy and safety of immunosuppressive therapy in Coronavirus disease-2019 (COVID-19) still controversial. We evaluated the effects of immunosuppressive therapy on mortality in patients followed in the intensive care units (ICU) due to critical COVID-19 pneumonia.Methods:We compared patients followed up in the ICUs due to severe COVID-19 pneumonia who received immunosuppressive therapy with those who did not in terms of 1-month mortality, retrospectively.Results:A total of 362 patients followed up in ICUs with a diagnosis of critical COVID-19 pneumonia were included in the study. The patients were divided into two groups as patients who received immunosuppressive therapy [n=249, 165 patients (45.5%) who received only corticosteroids, 25 patients (7%) who received only tocilizumab, and 59 patients (16.5%) who received tocilizumab + corticosteroid] and patients who did not (n=113). One hundred and ninety-two of the patients died (54.1%). There was no statistical difference between the groups in terms of 1-month mortality (p=0.38). Secondary bacterial infection was detected in 25.1% (n=91) n of the patients. The frequency of secondary infections was higher in the patients who received immunosuppressive therapy than in patients who did not receive immunosuppressive therapy (28% vs 17% respectively, p=0.03). The most common secondary bacterial infection was detected in patients who received tocilizumab + corticosteroids (n=25, 42.2%).Conclusion:In this study, no difference in 1-month mortality was found between patients who received immunosuppressive therapy and those who did not. The frequency of secondary bacterial infections in patients who received immunosuppressive therapy was higher than in patients who did not. |
| first_indexed | 2024-04-10T12:49:04Z |
| format | Article |
| id | doaj.art-ff6de0c177dd46cf88108919842ac4a1 |
| institution | Directory Open Access Journal |
| issn | 2619-9793 2148-094X |
| language | English |
| last_indexed | 2024-04-10T12:49:04Z |
| publishDate | 2022-05-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | İstanbul Medical Journal |
| spelling | doaj.art-ff6de0c177dd46cf88108919842ac4a12023-02-15T16:13:55ZengGalenos Yayineviİstanbul Medical Journal2619-97932148-094X2022-05-0123211311810.4274/imj.galenos.2022.8642913049054The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 PneumoniaÖmer Ayten0İnşa Gül Ekiz İşcanlı1Ekiz İşcanlı2Gözde Kalbaran Kısmet3Cengiz Özdemir4Bengü Şaylan5 University of Health Sciences Turkey, Sultan 2. Abdülhamid Han Training and Research Hospital, Clinic of Pulmonary Medicine, İstanbul, Turkey University of Health Sciences Turkey, Sultan 2. Abdülhamid Han Training and Research Hospital, Clinic of Intensive Care Unit, İstanbul, Turkey University of Health Sciences Turkey, Sultan 2. Abdülhamid Han Training and Research Hospital, Clinic of Pulmonary Medicine, İstanbul, Turkey University of Health Sciences Turkey, Sultan 2. Abdülhamid Han Training and Research Hospital, Clinic of Pulmonary Medicine, İstanbul, Turkey University of Health Sciences Turkey, Yedikule Chest Diseases and Thoracic Surgery Training and Reseaarch Hospital, Clinic of Pulmonary Medicine, İstanbul, Turkey University of Health Sciences Turkey, Sultan 2. Abdülhamid Han Training and Research Hospital, Clinic of Pulmonary Medicine, İstanbul, Turkey Introduction:The efficacy and safety of immunosuppressive therapy in Coronavirus disease-2019 (COVID-19) still controversial. We evaluated the effects of immunosuppressive therapy on mortality in patients followed in the intensive care units (ICU) due to critical COVID-19 pneumonia.Methods:We compared patients followed up in the ICUs due to severe COVID-19 pneumonia who received immunosuppressive therapy with those who did not in terms of 1-month mortality, retrospectively.Results:A total of 362 patients followed up in ICUs with a diagnosis of critical COVID-19 pneumonia were included in the study. The patients were divided into two groups as patients who received immunosuppressive therapy [n=249, 165 patients (45.5%) who received only corticosteroids, 25 patients (7%) who received only tocilizumab, and 59 patients (16.5%) who received tocilizumab + corticosteroid] and patients who did not (n=113). One hundred and ninety-two of the patients died (54.1%). There was no statistical difference between the groups in terms of 1-month mortality (p=0.38). Secondary bacterial infection was detected in 25.1% (n=91) n of the patients. The frequency of secondary infections was higher in the patients who received immunosuppressive therapy than in patients who did not receive immunosuppressive therapy (28% vs 17% respectively, p=0.03). The most common secondary bacterial infection was detected in patients who received tocilizumab + corticosteroids (n=25, 42.2%).Conclusion:In this study, no difference in 1-month mortality was found between patients who received immunosuppressive therapy and those who did not. The frequency of secondary bacterial infections in patients who received immunosuppressive therapy was higher than in patients who did not. http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-effects-of-mmunosuppressive-therapy-on-mortali/52047 covid-19immunosuppressive therapytocilizumabcorticosteroidmortality |
| spellingShingle | Ömer Ayten İnşa Gül Ekiz İşcanlı Ekiz İşcanlı Gözde Kalbaran Kısmet Cengiz Özdemir Bengü Şaylan The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia İstanbul Medical Journal covid-19 immunosuppressive therapy tocilizumab corticosteroid mortality |
| title | The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia |
| title_full | The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia |
| title_fullStr | The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia |
| title_full_unstemmed | The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia |
| title_short | The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia |
| title_sort | effects of immunosuppressive therapy on mortality in patients followed in intensive care units with the diagnosis of critical coronavirus disease 2019 pneumonia |
| topic | covid-19 immunosuppressive therapy tocilizumab corticosteroid mortality |
| url |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-effects-of-mmunosuppressive-therapy-on-mortali/52047
|
| work_keys_str_mv | AT omerayten theeffectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT insagulekiziscanlı theeffectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT ekiziscanlı theeffectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT gozdekalbarankısmet theeffectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT cengizozdemir theeffectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT bengusaylan theeffectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT omerayten effectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT insagulekiziscanlı effectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT ekiziscanlı effectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT gozdekalbarankısmet effectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT cengizozdemir effectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia AT bengusaylan effectsofimmunosuppressivetherapyonmortalityinpatientsfollowedinintensivecareunitswiththediagnosisofcriticalcoronavirusdisease2019pneumonia |